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Abstract
Background: Vitamin D deficiency and vitamin D receptor gene polymorphisms are known to be significantly
associated with high myopia. Whether this genetic variant may impact primary open-angle glaucoma is
largely unknown. This study investigated whether vitamin D receptor gene polymorphisms are altered in
primary open-angle glaucoma subjects carrying the risk allele, and whether vitamin D deficiency is an
important factor in the development of glaucoma.
Methods: Seventy-three POAG patients and 71 age-matched controls from the Han population were enrolled. Serum
levels of 1a, 25-Dihydroxyvitamin D3 were measured by enzyme-linked immunoabsorbent assay. Vitamin D receptor
polymorphisms (Cdx-2, Fok I, Bsm I and Taq I) were analyzed using real-time polymerase-chain reaction high resolution
melting analysis.
Results: Serum levels of 1a, 25-Dihydroxyvitamin in primary open-angle glaucoma patients were lower than in
age-matched controls. Statistical analysis revealed a significant difference in the allelic frequencies of the BsmI and TaqI
genotypes between primary open-angle glaucoma patients and age-matched controls, while other polymorphisms did
not show any significant differences.
Conclusions: Vitamin D deficiency and the presence of the BsmI ‘B’ allele and the TaqI ‘t’ allele are relevant risk factors in
the development of glaucoma.
Trial registration: Clinical Trials.gov: NCT02539745.
The study was registered retrospectively on August 3rd, 2015. The first participant was enrolled on July 4th, 2013.
Keywords: Vitamin D deficiency, Vitamin D receptor, Polymorphism, Primary open-angle glaucoma
Background
Glaucoma is characterized by typical structural damage
to the optic nerve, specific visual field defects, and often
relatively higher intraocular pressure (IOP) [1, 2]. It is
also a complex inherited disorder for which an increas-
ing number of genetic associations have been described,
each contributing modestly to disease burden [3].
Primary open-angle glaucoma (POAG) is the most
common type of glaucoma in all populations [4]. The
molecular mechanisms leading to the pathogenesis of
POAG are not completely understood. Genetic factors
have been regarded as a critical risk factor in the patho-
genesis of POAG [5]. Although the gene mutations in
various populations have been identified by genetic stud-
ies and a genetic basis for POAG pathogenesis has been
established [6–9], further identification of the genetic
basis of glaucoma should help delineate the pathogenesis
of the disease [10].
Vitamin D is now recognized as a versatile signaling
molecule rather than being solely a regulator of bone
health and calcium homeostasis [11]. It is involved in
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the modulation of different biological processes, includ-
ing skeletal metabolism, immunological response, prolif-
eration and differentiation of cells [12]. 1a, 25-
Dihydroxyvitamin D3 is the endogenously produced,
hormonally active form of vitamin D. 1a, 25-
Dihydroxyvitamin D3 elicits its action on target tissues
through the single vitamin D receptor (VDR) [13–18].
Recent studies have demonstrated an association be-
tween vitamin D levels and myopia; vitamin D deficiency
has been shown to influence the development of high
myopia [19]. Many clinical and research studies have
shown that high myopia and glaucoma are closely asso-
ciated and have proved that myopia was a risk factor for
POAG [20–22]. Vitamin D levels are also associated
with glaucoma. A recent article proposed that 1a, 25-
Dihydroxyvitamin D3, or an analog thereof, may be used
to treat glaucoma [23, 24]. Therefore, serum 25-
Dihydroxyvitamin D3 levels may be of critical concern
to POAG patients.
The vitamin D receptor gene (VDR) has been identi-
fied as a genetic factor that may contribute to spine
pathologies [25, 26]. Several single nucleotide polymor-
phisms (SNPs) have been identified in the VDR sequence
[13, 27]. The presence of VDR gene polymorphisms has
been regarded as a critical risk factor in the development
of ocular disease. For instance, FokI polymorphism has
been associated with high myopia [13].
Few studies have shown an association between vita-
min D deficiency and glaucoma, and there are no previ-
ous studies relating VDR gene polymorphisms to the
development of glaucoma. In this study, we will evaluate
whether vitamin D deficiency and Cdx-2, FokI, BsmI
and TaqI polymorphisms of the VDR gene are associated
with POAG in the Han population of China. The
present study can provide a platform to help explain the
pathological mechanism of POAG and demonstrate the
geographic and ethnic differences which were associated
with disease incidence and mortality.
Methods
Subjects
This was a hospital-based and case–control study. 71
POAG patients and 73 randomly selected age-matched
controls from the Han population at Tianjin Medical
University Eye Hospital were voluntarily enrolled. The
group included 68 males and 76 females, with ages ran-
ging from 55–65 years. All individuals underwent stan-
dardized clinical examinations for glaucoma at Tianjin
Medical University Eye Hospital during 2013–2014.
These examinations include slit-lamp biomicroscopy,
gonioscopy, automated visual field testing (Octopus G1;
Interzeag, Schlieren, Switzerland), fundus photography
(Carl Zeiss Meditec, Oberkochen, Germany), optional
laser scanning tomography (HRT II; Heidelberg
Engineering, Heidelberg, Germany) of the disc and a 24-
h Goldmann-applanation intraocular pressure (IOP) to-
nometry profile with six measurements [28]. All POAG
patients met the following four inclusion criteria [29–
32]: (1) intraocular pressure greater than 21 mmHg or
more in each eye without therapy; (2) wide anterior
chamber angle; (3) glaucomatous optic neuropathy
(glaucomatous optic nerve damage was defined as cup-
to-disc ratio higher than 0.7 or focal loss of the nerve
fiber layer (notch) associated with a consistent glau-
comatous visual field defect in at least one eye); (4) vis-
ual field loss consistent with optic nerve damage (visual
fields were determined using standard automated perim-
etry in at least one eye). Exclusion criteria included the
presence of any secondary glaucoma including exfoli-
ation syndrome or a history of ocular trauma, high my-
opia, macular degeneration, other ocular diseases, a
known history of systemic diseases, and administration
of vitamin D3 or other analog. The controls were also
checked for anterior chamber angle, fundus, and intraoc-
ular pressure, based on their past medical records and
interviews. The controls were selected based on criteria
which included: no family history of glaucoma or ocular
hypertension; IOP less than 20 mmHg in both eyes in at
least one of their last two checkups; CCT greater than
500 μm in both eyes; no visual field defect; cup discs
that were physiologic and similar in both eyes; a cup-to-
disc ratio <0.2; no defect in disc rim or margin; and no
splinter hemorrhage around the disc. Individuals with
high myopia, macular degeneration, hypertension, sys-
temic diseases, family history of glaucoma, or a history
of administration of vitamin D3 or its analog were ex-
cluded from the control group.
Blood sample processing and biomarker assays
Fasting blood samples were drawn at 8 am from all study
participants. Ethylenediaminetetraacetic acid (EDTA K2)
blood-collection tubes were immediately stored on ice
and then centrifuged within 30 min at 2,300 rpm for
15 min at 4°C. The separated plasma was immediately
transferred to polypropylene tubes and stored at −20°C.
Serum levels of 1a, 25-Dihydroxyvitamin D3 were mea-
sured by enzyme-linked immunoabsorbent assay, using
commercially available kits (Trust Specialty Zeal biological
trade Co., Ltd., U.S.A). 1a, 25-Dihydroxyvitamin D3 was
measured in ng/ml, according to previously described
methods [33].
Sodium citrate blood-collection tubes were stored at
−20°C. Genomic DNA from the blood samples was ex-
tracted using a DNA Extraction Kit (TIANGEN) and
stored at 4°C. DNA was screened for Cdx-2, FokI, BsmI
and TaqI mutations of VDR gene [34] using high reso-
lution melting analysis (PCR-HRM) on a Roche LightCy-
cler480 platform. All the mutations detected in HRM
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were confirmed by sequencing. All the primers were as
described before (Table 1). Cdx-2, FokI, BsmI and TaqI
are reported according to the standard nomenclature in
which lowercase and uppercase letters indicate the pres-
ence or absence of a restriction site, respectively. The FokI
T and C alleles are represented by f and F, the BsmI G and
A alleles by b and B, and the TaqI T and C alleles by t and
T, respectively, and the Cdx-2 binding site polymorphism
(G to A) in the promoter region of the human vitamin D
receptor gene alleles by G and A [35, 36].
Statistical analysis
Age comparison between POAG patients and age-
matched controls was analyzed using Student’s t test. Gen-
der comparison between the two groups was analyzed
using a chi-square test. A power analysis using PASS soft-
ware was used to assess the sample size. Statistical differ-
ences of serum levels of 1a, 25-Dihydroxyvitamin D3
between the two groups were evaluated by Student’s t test.
Statistical differences of genotype and allele frequencies of
patients with POAG were evaluated by chi-square test
and logistic regression analysis. The odds ratio (OR) and
95 % confidence interval (CI) were calculated to assess the
relative risk of POAG in relation to a specific allele [28].
Statistical analysis used SPSS17.0 software and p < 0.05
was considered statistically significant.
Results
Age and gender comparisons between POAG patients
and age-matched controls were not statistically sig-
nificant (p>0.05) (Tables 2, and 3). Sample size ana-
lysis using PASS software produced a power of 0.998
in this study.
Analysis of serum levels of 1a, 25-Dihydroxyvitamin D3
Serum levels of 1a, 25-Dihydroxyvitamin D3 were mea-
sured for both 71 POAG patients and 73 age-matched
controls. The mean ± SD serum levels of 1 a, 25-
Dihydroxyvitamin D3 were 30.43 ± 3.91 ng/ml in age-
matched controls and 26.37 ± 5.83 ng/ml in POAG pa-
tients. The serum levels of 1 a, 25-Dihydroxyvitamin D3
in age-matched controls was significantly higher than
the levels in POAG patients. (p < 0.001) (Table 4).
Analysis of allele and genotype frequencies of VDR gene
polymorphism with respect to POAG (Table 5)
VDR polymorphic analysis (Cdx-2, Fok I, Bsm I and
Taq I) was performed using PCR-HRM (Fig. 1 a: Cdx-2,
b: Fok I, c:Bsm I, d: Taq I).
The genotype distribution of the Cdx-2 polymorphism
in POAG patients revealed a considerable increase in
the frequency of the GG homozygote (43.66 %) com-
pared to the control group (35.62 %), a decrease in the
frequency of the AA homozygote (18.31 %) compared to
the control group (20.56 %), and a corresponding de-
crease in the frequency of AG heterozygote (38.03 % in
POAG vs. 43.83 % in controls) without much variation
in heterozygote frequencies (P =0.613; χ2 = 0.978). The
allelic distribution revealed reduction in the G allele fre-
quency (GG and AG) in POAG patients (62.68 %) com-
pared to the control group (57.53 %) (p = 0.427; χ2 =
0.632; OR = 1.239, 95 % CI: 0.773 ~ 1.998).
The genotype distribution of the Fok1 polymorphism
in POAG patients revealed a considerable increase in
the frequency of the FF homozygote (26.76 %) compared
to the control group (26.02 %), an increase in the fre-
quency of the Ff heterozygote (49.30 %) compared to the
control group (36.99 %), and a corresponding decrease
in the frequency of the ff homozygote (23.94 % in POAG
vs. 36.99 % in controls) without much variation in het-
erozygote frequencies (p = 0.194; χ2 = 3.278). The allelic
distribution revealed an increase in the F allele frequency
(FF and Ff) in POAG patients (51.41 %) as compared to
that of control group (44.52 %) (p = 0.242; χ2 = 1.368;
OR = 1.318, 95 % CI:0.829 ~ 2.096).
The genotype distribution of the BsmI polymorphism in
POAG patients revealed a considerable increase in the fre-
quency of the Bb heterozygote (25.35 %) compared to the
control group (5.48 %), and a corresponding decrease in
the frequency of the bb homozygote (74.65 % in POAG
vs. 94.52 % in controls) with much variation in heterozy-
gote frequencies (p = 0.001; χ2 = 10.982). The allelic distri-
bution revealed reduction in the B allele frequency (Bb) in
POAG patients (12.68 %) compared to the control group
(2.74 %) (p = 0.002; χ2 = 10.074; OR = 5.153, 95 % CI:
1.699 ~ 15.635).
The genotype distribution of the Taq I polymorph-
ism in POAG patients revealed a considerable de-
crease in the frequency of the TT homozygote
(74.65 %) compared to the control group (90.41 %),
Table 1 Primers for VDR gene polymorphisms (Cdx-2,FokI,BsmI and TaqI) (GenBank AY342401)
SNP Primer(5’→ 3’) Primer(5’→ 3’) bp
Cdx-2 GGGTCTTCCCAGGACAGTAT GGAATGAAAGAGGGAAGGAG 191
FokI GTCAGGCAGGGAAGTGCTG CTGGCACTGACTCTGGCTC 86
BsmI GCAAGAAACCTCAAATAACAGG ATTCTGAGGAACTAGATAAGCAGG 121
TaqI TACGTCTGCAGTGTGTTGGA CTGAGAGCTCCTGTGCCTTC 115
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with a corresponding increase in the frequency of the
Tt heterozygote (23.35 % in POAG vs. 9.59 % in
controls) and much variation in heterozygote frequen-
cies (p = 0.013; χ2 = 6.234). The allelic distribution
revealed an increase in the t allele frequency (Tt) in
POAG patients (12.68 %) compared to the control
group (4.79 %) (p = 0.018; χ2 = 5.641; OR = 2.882, 95 %
CI:1.165 ~ 7.132).
Discussion
Vitamin D deficiency may affect the incidence and
progression of POAG
Vitamin D is an inactive precursor when produced in
the skin utilizing the energy of sunlight or when
ingested as a dietary vitamin D [11, 12]. It requires
two hydroxylation steps: first in the liver and then in
the kidney [11]. It can be converted to 1α, 25-
dihydroxyvitamin D3, which is the active hormone
[11, 17, 18]. Levels of 1a, 25-Dihydroxyvitamin D3
are controlled by numerous factors. In low-calcium
states, levels of 1a, 25-Dihydroxyvitamin D3 increase
due to parathyroid hormone activity increases. How-
ever, in serious low-calcium states, when the substrate
is exhausted, levels of 1a, 25-Dihydroxyvitamin D3
decrease [17, 18, 37]. In this study, serum levels of
1a, 25-Dihydroxyvitamin D3 in POAG patients were
significantly lower than age-matched controls. These
results suggest that Vitamin D deficiency might con-
tribute to an increase in the incidence of POAG and
may play an important role in the development of
POAG. In POAG patients, the cause of 1a, 25-
Dihydroxyvitamin D3 deficiency is unclear. However,
topical administration of 1a, 25-dihydroxyvitamin D3
markedly reduces IOP in non-human primates [23].
The exact mechanism by which 1a, 25-(OH)2D3 re-
duces IOP is also unclear.
The BsmI ‘B’ allele and the TaqI ‘t’ allele may affect the
development pathway of POAG
1a, 25-dihydroxyvitamin D3 regulates genes that are known
to be involved in the determination of intraocular pressure
(IOP) [23]. Moreover, ocular hypertension is the greatest
known risk factor for POAG. The currently accepted mech-
anism is that vitamin D implements its functions through a
VDR [17–20], which is present in most cell types in tissues.
When 1α, 25-dihydroxyvitamin D3 binds to the VDR, it
forms 1α, 25-dihydroxyvitamin D3/VDR complexes, regu-
lating multiple target genes in tissues containing the VDR
[21, 22]. The VDR not only regulates transcriptional re-
sponses but is also involved in micro RNA-directed post-
transcriptional mechanisms [25, 26]. In humans, VDR is
Table 4 Serum levels of 1a, 25-Dihydroxyvitamin D3 comparing
POAG patients with age-matched people
Group n 1a, 25-Dihydroxyvitamin D3 t value P value
Mean SD
Control 73 30.43 3.91 4.920 <0.001
POAG 71 26.37 5.83
Table 5 Genotype distributions and allelic genes of VDR gene




Control POAG X2 P value OR(95%CI)
(n = 73) (n = 71)
Cdx-2
GG 26 31 0.978 0.613
AG 32 27
AA 15 13
G 84 89 0.632 0.427 1.239 (0.773 ~ 1.988)
A 62 53
FokI
FF 19 19 3.278 0.194
Ff 27 35
ff 27 17
F 65 73 1.368 0.242 1.318 (0.829 ~ 2.096)
f 81 69
BsmI
Bb 4 18 10.982 0.001 5.858 (1.872 ~ 18.337)
bb 69 53
B 4 18 10.074 0.002 5.153 (1.699 ~ 15.635)
b 142 124
TaqI
TT 66 53 6.234 0.013
Tt 7 18 3.202 (1.245 ~ 8.238)
T 139 124 5.641 0.018
t 7 18 2.882 (1.165 ~ 7.132)
Table 2 Age comparison between POAG patients and age-
matched people
Group n age t value P value
Mean SD
Control 73 60.14 3.03 1.844 0.067
POAG 71 61.03 2.75
Table 3 Gender comparison between POAG patients and age-
matched people
Group n male female X2 P value
Control 73 29 44 3.338 0.068
POAG 71 39 32
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involved in retinoid functions of the eye such as accommo-
dation, pupil responses, and aqueous humor production,
and may have an indirect and functional role in ocular
growth and myopia development [13, 23].
The VDR gene encodes the VDR. Several single nu-
cleotide polymorphisms (SNPs) have been identified in
the VDR gene, which truncate the VDR protein, such as
FokI at the 5’ end of exon 2 (rs10735810), Cdx-2 binding
site locus upstream of exon 1e (rs11568820), BsmI in in-
tron 8 (rs1544410) and TaqI in exon 9 (rs731236) in the
3’UTR region [27, 33, 34]. In this study, each SNP dem-
onstrated the Hardy-Weinberg equilibrium. Statistical
analysis revealed a significant difference in the allelic fre-
quencies of the BsmI and TaqI genotypes, while other
polymorphisms did not show any significant differences.
The protective actions of the BsmI ‘B’ allele and the Taq
I ‘t’ allele were confirmed experimentally, leading to a
better understanding of the pathological mechanism of
glaucoma. Firstly, VDR gene polymorphisms can regu-
late the metabolism of vitamin D by positive and nega-
tive feedback, including the metabolism of 1a, 25-
Dihydroxyvitamin D3. Secondly, the BsmI and TaqI in
the 3’UTR region may be relevant to VDR mRNA stabil-
ity and gene transcription, which is involved in the fol-
lowing: production and outflow of aqueous humor,
remodeling of the extracellular matrix in the trabecular
meshwork, controlling intraocular pressure and partici-
pating in the development of POAG. Therefore, the
BsmI ‘B’allele and the TaqI ‘t’ allele may be important
risk factors in the development of glaucoma.
Conclusions
Vitamin D deficiency, the BsmI ‘B’allele and the TaqI ‘t’ al-
lele point to their direct roles in POAG development.
However, the causes of 1a, 25-Dihydroxyvitamin D3 defi-
ciency, the changes in the structure and function of VDR
and the frequency of allele carriers of polymorphisms of
VDR require further study. The possibility of administer-
ing vitamin D3 to POAG patients who have low levels of
1a, 25-Dihydroxyvitamin D3, and the question of whether
1a, 25-Dihydroxyvitamin D3 affects intraocular pressure
should be further investigated.
Fig. 1 Genotypes of VDR gene (a: Cdx-2, b: Fok I, c:Bsm I, d: Taq I) polymorphisms were determined by PCR-HRM
Lv et al. BMC Ophthalmology  (2016) 16:116 Page 5 of 7
Abbreviations
IOP, intraocular pressure; POAG, primary open-angle glaucoma; PAC, primary
angle closure; EDTA K2, ethylenediaminetetraacetic acid; SNPs, single nucleo-
tide polymorphisms; OR, odds ratio; CI, confidence interval; VDR, vitamin D
receptor; SD, standard deviation; n, number
Acknowledgements
The authors gratefully acknowledge Elizabeth Conroy for proofreading.
Funding
This work was supported by a grant from Tianjin Municipal Health Bureau
Item of China (Grant number2013KZ115), a grant from Tianjin Higher
Educational Science and Technology Program (Grant number 20130133), a
grant from Tianjin Municipal Science and Technology Commission (Grant
number15JCQNJC13200) and a grant from Tianjin Medical University Science
Foundation (Grant number 2011ky36).
Availability of data and materials
Data can be shared upon request.
Authors’ contributions
LXR making conception; LYJ design, acquisition, analysis and interpretation
of the data and writing the manuscript; LH statistical analysis; MWJ serum
levels of 1a, 25-Dihydroxyvitamin D3 analysis by enzyme-linked immunoab-
sorbent assay; YQB vitamin D receptor polymorphic (Cdx-2, Fok I, Bsm I and
Taq I) analysis by real-time polymerase-chain reaction high resolution melt-
ing analysis; JJ revision of the manuscript. All authors read and approved the
final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
A written informed consent to publish study participant’s data was sought
along with the consent for participation into the study.
Ethics approval and consent to participate
This study protocol adhered to the tenets of the Declaration of Helsinki and
was reviewed by the ethics committee of Tianjin Medical University Eye
Hospital. All patients gave written consent to have their blood samples used
for DNA analyses, and all have been informed of the results of the analyses.
Author details
1Department of Glaucoma, Tianjin Medical University Eye Hospital, Tianjin
Medical University Eye Institute, The School of Optometry&Ophthalmology,
No.251 Fu Kang Road, Nan kai District, Tianjin 300384, China. 2Department of
Histology and Embryology, Tianjin Medical University, No. 22 Qi Xiang Tai
Road, He Ping District, Tianjin 300070, China.
Received: 8 November 2015 Accepted: 5 July 2016
References
1. Tehrani S. Gender difference in the pathophysiology and treatment of
glaucoma. Curr Eye Res. 2015;40(2):191–200.
2. Quigley HA, Broman AT. The number of people with glaucoma worldwide
in 2010 and 2020. Br J Ophthalmol. 2006;90:262–7.
3. Liu Y, Allingham RR. Molecular genetics in glaucoma. Exp Eye Res. 2011;93:
331–9.
4. Burdon KP. Genome-wide association studies in the hunt for genes causing
primary open-angle glaucoma: a review. Clin Experiment Ophthalmol. 2012;
40:358–63.
5. Janssen SF, Gorgels TG, Ramdas WD, Klaver CC, van Duijn CM, Jansonius
NM, et al. The vast complexity of primary open angle glaucoma: disease
genes, risks, molecular mechanisms and pathobiology. Prog Retin Eye Res.
2013;37:31–67.
6. Gemenetzi M, Yang Y, Lotery AJ. Current concepts on primary open-angle
glaucoma genetics: a contribution to disease pathophysiology and future
treatment. Eye (Lond). 2012;26(3):355–69.
7. Khan AO. Genetics of primary glaucoma. Curr Opin Ophthalmol. 2011;
22(5):347–55.
8. Fingert JH. Primary open-angle glaucoma genes. Eye (Lond). 2011;
25(5):587–95.
9. Huang X, Li M, Guo X, Li S, Xiao X, Jia X, et al. Mutation analysis of seven
known glaucoma-associated genes in Chinese patients with glaucoma.
Invest Ophthalmol Vis Sci. 2014;55(6):3594–602.
10. Abecia E, Martínez-Jarreta B, Casalod Y, Bell B, Pinilla I, Honrubia FM.
Genetic markers in primary open-angle glaucoma. Int Ophthalmol.
1996–1997;20(1–3):79–82.
11. Carlberg C. Mechanisms of nuclear signalling by vitamin D3. Interplay
with retinoid and thyroid hormone signalling. Eur J Biochem. 1995;
231(3):517–27.
12. Schräder M, Bendik I, Becker-André M, Carlberg C. Interaction between
retinoic acid and vitamin D signaling pathways. J Biol Chem. 1993;268:
17830–6.
13. Ferrari S, Bonjour JP, Rizzoli R. The vitamin d receptor gene and calcium
metabolism. Trends Endocrinol Metab. 1998;9(7):259–65.
14. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, et al.
The nuclear receptor superfamily: the second decade. Cell. 1995;83(6):835–9.
15. Carlberg C. The vitamin D3 receptor in the context of the nuclear receptor
superfamily: the central role of retinoid Xreceptor. Endocrine. 1996;4:91–105.
16. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G,
et al. 9-Cis retinoic acid stereoisomer binds and activates the nuclear
receptor RXRa. Nature (London). 1992;355:359–61.
17. Carlberg, C. Critical analysis of 1a, 25-dihydroxyvitamin D3 response
elements. Proc. 10th Int. Vit. D Workshop. 1997; 268–275
18. Morrison NA, Shine J, Fragonas J-C, Verkest V, McMenemey ML, Eisman JA.
1, 25-dihydroxyvitaminD-responsive element and glucocorticoid repression
in the osteocalcin gene. Science. 1989;246:1158–61.
19. Annamaneni S, Bindu CH, Reddy KP, Vishnupriya S. Association of vitamin D
receptor gene start codon (Fok1) polymorphism with high myopia. Oman J
Ophthalmol. 2011;4(2):57–62.
20. Ma F, Dai J, Sun X. Progress in understanding the association between high
myopia and primary open-angle glaucoma. Clin Experiment Ophthalmol.
2014;42(2):190–7.
21. Chang RT, Singh K. Myopia and glaucoma: diagnostic and therapeutic
challenges. Curr Opin Ophthalmol. 2013;24(2):96–101.
22. Marcus MW, de Vries MM, Junoy Montolio FG, Jansonius NM. Myopia as a
risk factor for open-angle glaucoma: a systematic review and meta-analysis.
Ophthalmology. 2011;118(10):1989–94.
23. Kutuzova GD, Gabelt BT, Kiland JA, Hennes-Beann EA, Kaufman PL, DeLuca
HF. 1α,25-Dihydroxyvitamin D(3) and its analog, 2-methylene-19-nor-(20S)-
1α,25-dihydroxyvitamin D(3) (2MD), suppress intraocular pressure in non-
human primates. Arch Biochem Biophys. 2012;518(1):53–60.
24. GUIST G, STEFFEN C. Application and mechanism of high dosage of vitamin
D therapy of glaucoma. Klin Monbl Augenheilkd Augenarztl Fortbild. 1953;
123(5):555–68.
25. Moras D, Gronemeyer H. The nuclear receptor ligand-binding domain:
structure and function. Curr Opin Cell Biol. 1998;10:384–91.
26. Torchia J, Glass C, Rosenfeld MG. Co-activators and co-repressors in the
integration of transcriptional responses. Curr Opin Cell Biol. 1998;10:373–83.
27. Heishi M, Tazawa H, Matsuo T, Saruta T, Hanaoka M, Tsukamoto Y. A novel
Van91 I polymorphism in the 1st intron of the parathyroid hormone (PTH)/
PTH-related peptide (PTHrP) receptor gene and its effect on the urinary
cAMP response to PTH. Biol Pharm Bull. 2000;23(4):386–9.
28. Pasutto F, Mardin CY, Michels-Rautenstrauss K, Weber BHF, Sticht H,
Chavarria-Soley G, et al. Profiling of WDR36 Missense Variants in German
Patients with Glaucoma. Invest Ophthalmol Vis Sci. 2008;49(1):270–4.
29. Xiao H, Liu X, Zhong Y, Mao Z. The influence of surgical and medical
interventions upon optic disc structure in patients with primary open angle
glaucoma. Eye science. 2011;26:185–92.
30. Allingham RR, Wiggs JL, Hauser ER, Larocque-Abramson KR, Santiago-Turla
C, Broomer B, et al. Early adult-onset POAG linked to 15q11-13 using
ordered subset analysis. Invest Ophthalmol Vis Sci. 2005;46(6):2002–5.
31. Quigley HA, Tielsch JM, Katz J, Sommer A. Rate of progression in
open-angle glaucoma estimated from cross-sectional prevalence of
visual field damage. Am J Ophthalmol. 1996;122(3):355–63.
32. Asman P, Heijl A. Glaucoma hemifield test: automated visual field
evaluation. Arch Ophthalmol. 1992;110:812–9.
33. de Sousa Studart SA, Leite AC, Marinho AL, Pinto AC, Rabelo Júnior CN, de
Melo Nunes R, Rocha HA, et al. Vitamin D levels in juvenile idiopathic
arthritis from an equatorial region. Rheumatol Int. 2015 May 20
Lv et al. BMC Ophthalmology  (2016) 16:116 Page 6 of 7
34. Seeratanachot T, Sanguansermsri T, Shimbhu D. Detection of Hb H disease
genotypes common in northern Thailand by quantitative real-time
polymerase chain reaction and high resolution melting analyses.
Hemoglobin. 2013;37(6):574–83.
35. Bai Y, Yu Y, Yu B, Ge J, Ji J, Lu H, et al. Association of vitamin D receptor
polymorphisms with the risk of prostate cancer in the Han population of
Southern China. BMC Med Genet. 2009;10:125.
36. Mostowska A, Lianeri M, Wudarski M, Olesińska M, Jagodziński PP. Vitamin D
receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of
systemic lupus erythematosus. Mol Biol Rep. 2013;40(2):803–10.
37. Krefting EA, Jorde R, Christoffersen T, Grimnes G. Vitamin D and intraocular
pressure–results from a case–control and an intervention study. Acta
Ophthalmol. 2014;92(4):345–9.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Lv et al. BMC Ophthalmology  (2016) 16:116 Page 7 of 7
